HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid

structure given in first source; a chelating agent that can be conjugated to monoclonal antibodies
Also Known As:
CTPA
Networked: 876 relevant articles (38 outcomes, 158 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Huisman, Menno V: 16 articles (04/2022 - 09/2011)
2. Klok, Frederikus A: 15 articles (04/2022 - 09/2011)
3. Kroft, Lucia J M: 10 articles (04/2022 - 09/2011)
4. Liu, Min: 10 articles (06/2020 - 01/2010)
5. Huisman, M V: 8 articles (08/2021 - 09/2009)
6. Kazerooni, Ella A: 8 articles (09/2017 - 06/2005)
7. Beenen, Ludo F M: 7 articles (04/2022 - 12/2013)
8. Middeldorp, Saskia: 7 articles (04/2022 - 12/2013)
9. Kline, Jeffrey A: 7 articles (01/2020 - 05/2010)
10. Henzler, Thomas: 7 articles (01/2019 - 01/2011)

Related Diseases

1. Pulmonary Embolism
2. Pulmonary Hypertension
3. COVID-19
4. Neoplasms (Cancer)
5. Pneumonia (Pneumonitis)

Related Drugs and Biologics

1. fibrin fragment D (D-dimer)
2. Anticoagulants
3. 2-(4-chlorophenylthio)triethylamine
4. Contrast Media
5. Iodine
6. Gadolinium
7. Proteins (Proteins, Gene)
8. Antigens
9. cupric sulfide (CuS)
10. Brain Natriuretic Peptide (Natrecor)

Related Therapies and Procedures

1. Catheters
2. Endarterectomy (Thromboendarterectomy)
3. Kyphoplasty
4. Therapeutics
5. Drug Tapering